| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- article scientific (oc)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artikulong pang-agham (tl)
- artykuł naukowy (pl)
- artículu científicu (ast)
- bilimsel makale (tr)
- scienca artikolo (eo)
- teaduslik artikkel (et)
- tieteellinen artikkeli (fi)
- tudományos cikk (hu)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- επιστημονικό άρθρο (el)
- научна статия (bg)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- სამეცნიერო სტატია (ka)
- บทความทางวิทยาศาสตร์ (th)
- artikel ilmiah (id)
- bài báo khoa học (vi)
- naučni članak (sr-el)
- мақолаи илмӣ (tg-cyrl)
- научни чланак (sr-ec)
- article scientifique (fr)
- 2005 nî lūn-bûn (nan)
- 2005年の論文 (ja)
- 2005년 논문 (ko)
- artículo científico publicado en 2005 (es)
- наукова стаття, опублікована в липні 2005 (uk)
- 2005年学术文章 (zh-cn)
- 2005年学术文章 (zh-sg)
- 2005年学术文章 (zh-hans)
- 2005年学术文章 (wuu)
- 2005年学术文章 (zh-my)
- 2005年學術文章 (zh-hk)
- 2005年學術文章 (zh-tw)
- 2005年學術文章 (zh-hant)
- 2005年學術文章 (yue)
- 2005年學術文章 (zh-mo)
- 2005年学术文章 (zh)
- ১১ জুলাই ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn)
- scientific article published on 11 July 2005 (en)
- scientific article published on 11 July 2005 (en-ca)
- scientific article published on 11 July 2005 (en-gb)
- 2005 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված (hy)
- مقالة علمية نشرت في 11 يوليو 2005 (ar)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - Dong M Shin
- Merrill S Kies
- Matthew Arquette
- Nozar Azarnia
- Karel Dicke
|
| rdfs:label
| - Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (en)
- Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (nl)
|
| skos:prefLabel
| - Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (en)
- Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (nl)
|
| name
| - Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (en)
- Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (nl)
|
| author
| |
| author
| |
| title
| |
| title
| - Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)